R. Airatovich Gafanov

KEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC).

J. Larkin, M. Atkins, V. Matveev, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.